BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33034059)

  • 1. Planning and advocating for cervical cancer prevention in Kebbi State, Nigeria: Learning points for the global call to eliminate cervical cancer.
    Lawal IK; Suleiman AK; Bagudu Z; Kanmodi KK; Abdulsalam GA; Olakunle OS
    Int J Gynaecol Obstet; 2021 Jan; 152(1):26-31. PubMed ID: 33034059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low- and lower-middle-income countries.
    Kumar S; Khanduri A; Sidibe A; Morgan C; Torode J; Basu P; Bhatla N; Schocken C; Bloem P
    Int J Gynaecol Obstet; 2021 Jan; 152(1):32-39. PubMed ID: 33185283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experiences in the prevention and screening of cervical cancer within Thailand.
    Kengsakul M; Laowahutanont P; Wilailak S
    Int J Gynaecol Obstet; 2021 Jan; 152(1):48-52. PubMed ID: 33181003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Program organization rather than choice of test determines success of cervical cancer screening: Case studies from Bangladesh and India.
    Bhatla N; Nessa A; Oswal K; Vashist S; Sebastian P; Basu P
    Int J Gynaecol Obstet; 2021 Jan; 152(1):40-47. PubMed ID: 33205399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.
    Drolet M; Laprise JF; Martin D; Jit M; Bénard É; Gingras G; Boily MC; Alary M; Baussano I; Hutubessy R; Brisson M
    Lancet Infect Dis; 2021 Nov; 21(11):1598-1610. PubMed ID: 34245682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaling up cervical cancer prevention in Western Kenya: Treatment access following a community-based HPV testing approach.
    Mungo C; Ibrahim S; Bukusi EA; Truong HM; Cohen CR; Huchko M
    Int J Gynaecol Obstet; 2021 Jan; 152(1):60-67. PubMed ID: 32347550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic HPV vaccination: a major breakthrough in the fight against cervical cancer?
    Saleem A; Tristram A; Fiander A; Hibbitts S
    Minerva Med; 2009 Dec; 100(6):503-23. PubMed ID: 20010484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community.
    Egbon M; Ojo T; Aliyu A; Bagudu ZS
    BMC Public Health; 2022 Aug; 22(1):1611. PubMed ID: 36002832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (At Least) Once in Her Lifetime: Global Cervical Cancer Prevention.
    Castle PE; Pierz A
    Obstet Gynecol Clin North Am; 2019 Mar; 46(1):107-123. PubMed ID: 30683258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in cervical cancer screening and human papillomavirus vaccines.
    Feeley C
    J Br Menopause Soc; 2006 Mar; 12(1):19-23. PubMed ID: 16513018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
    El-Zein M; Richardson L; Franco EL
    J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs.
    Kulasingam SL; Myers ER
    JAMA; 2003 Aug; 290(6):781-9. PubMed ID: 12915431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point-registry-based follow-up of
    Lehtinen M; Lagheden C; Luostarinen T; Eriksson T; Apter D; Harjula K; Kuortti M; Natunen K; Palmroth J; Petäjä T; Pukkala E; Siitari-Mattila M; Struyf F; Nieminen P; Paavonen J; Dubin G; Dillner J
    BMJ Open; 2017 Aug; 7(8):e015867. PubMed ID: 28821519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) vaccines: prospects for eradicating cervical cancer.
    Stanley MA
    J Fam Plann Reprod Health Care; 2004 Oct; 30(4):213-5. PubMed ID: 15530217
    [No Abstract]   [Full Text] [Related]  

  • 16. Human papillomavirus vaccines versus cervical cancer screening.
    Stanley M
    Clin Oncol (R Coll Radiol); 2008 Aug; 20(6):388-94. PubMed ID: 18538554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Declining rates of cervical intraepithelial neoplasia in British Columbia, Canada: An ecological analysis on the effects of the school-based human papillomavirus vaccination program.
    Donken R; van Niekerk D; Hamm J; Spinelli JJ; Smith L; Sadarangani M; Albert A; Money D; Dobson S; Miller D; Lee M; Mitchell-Foster S; Krajden M; Naus M; Ogilvie G
    Int J Cancer; 2021 Jul; 149(1):191-199. PubMed ID: 33586169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F
    BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elimination of cervical cancer in low- and middle-income countries: Inequality of access and fragile healthcare systems.
    Vale DB; Teixeira JC; Bragança JF; Derchain S; Sarian LO; Zeferino LC
    Int J Gynaecol Obstet; 2021 Jan; 152(1):7-11. PubMed ID: 33128771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria.
    Azuogu BN; Umeokonkwo CD; Azuogu VC; Onwe OE; Okedo-Alex IN; Egbuji CC
    Niger J Clin Pract; 2019 Sep; 22(9):1286-1291. PubMed ID: 31489868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.